Sökresultat

This article is over 5 years old, and the information may therefore be outdated. Knut and Alice Wallenberg Foundation appointed Åsa Petersén Wallenberg Clinical Scholar in 2020. An article on Åsa's research is now published on the foundation's website. The Wallenberg Clinical Scholar is aimed for researchers combining their research with clinical work and is a grant for five years. The article on

https://www.huntington-research.lu.se/article/research-early-hd-symptoms-can-lead-new-treatment-strategies - 2026-08-19

This article is over 5 years old, and the information may therefore be outdated. TNU:s study on ALS together with Australian collaborators on Lund university's top news today. Åsa Petersén, Sanaz Gabery and collaborators in Australia have, for the first time, shown changes in hypothalamic neurons regulating metabolism, sleep and emotions in ALS patients. Since long, researchers have assumed that c

https://www.huntington-research.lu.se/article/new-publication-als-tnu-and-australian-collaborators - 2026-08-19

TNU published a new paper on early changes in the limbic system in Huntington disease together with international collaborators in Acta Neuropathologica, August 26, 2021. Link to article (opens in a new window): Early white matter pathology in the fornix of the limbic system in Huntington disease Link to Lund University webpage for news article on the the results (in Swedish): Känslohjärnan – en n

https://www.huntington-research.lu.se/article/important-paper-huntington-disease-gabery-et-al-acta-neuropathologica-2021 - 2026-08-19

Petersén and Gabery give talks about research at the National Huntington Meeting October 13, 2021. It is a digital meeting where you can see the talks at the home page of the Swedish patient organisation RHS:  https://huntington.se/13-oktober-valkomna-pa-nationellt-mote-kring-huntingtons-sjukdom/ (Opens a new window)  

https://www.huntington-research.lu.se/article/petersen-and-gabery-give-talks-about-research-national-huntington-meeting-october-13-202 - 2026-08-19

Petersén gives talks about research and clinical care for Huntington disease to young adults in HD families at a conference in Gothenburg October 21-24, 2021. See homepage of the patient organization Swedish Huntington Association (Riksförbundet för Huntingtons sjukdom) for more information:  Link to Swedish Huntington Association's webpage (opens in a new window)

https://www.huntington-research.lu.se/article/petersen-gives-talks-conference-young-people-hd - 2026-08-19

On 11-12 November 2021 the SWEMODIS annual meeting on Parkinson’s disease and other Movement Disorders took place in Stockholm, where Åsa Petersén gave a talk on Huntington's disease. SWEMODIS webpage (opens in a new window)

https://www.huntington-research.lu.se/article/petersen-gave-talk-annual-swemodis-meeting - 2026-08-19

Huntington disease is the topic of today’s episode of the radio program Kropp & Själ, Body & Mind, on the Swedish public service radio. The dilemma of genetic testing is one of the aspects of the disease discussed in the program, where Åsa Petersén is a guest. You can access today’s episode on Sveriges Radio’s website: https://sverigesradio.se/avsnitt/huntingtons-sjukdom-den-felande-genen (in Swed

https://www.huntington-research.lu.se/article/about-huntington-disease-swedish-radio - 2026-08-19

Petersén (PI) and Gabery (co-PI) received a research grant of 1.2 MSEK from the Swedish Brain Foundation (Hjärnfonden) for a project on novel mechanisms of disease and a potential future therapy for HD. Link to the Swedish Brain Foundation's webpage  

https://www.huntington-research.lu.se/article/research-grant-swedish-brain-foundation - 2026-08-19

Petersén (PI) received a research grant of 6 MSEK from the Swedish Research Council (Vetenskapsrådet) for 2023-2026 for a project on novel cellular and molecular mechanisms in the limbic system for psychiatric symptoms in Huntington disease. 

https://www.huntington-research.lu.se/article/research-grant-swedish-research-council - 2026-08-19

Åsa Petersén has been elected member of the executive committee for the European Huntington Disease Network (EHDN). The EHDN is a nonprofit research network committed to advancing research, facilitating the conduct of clinical trials, and improving clinical care in HD. Through the EHDN a platform has been created such that basic scientists, clinicians, patients and families can collaborate on acad

https://www.huntington-research.lu.se/article/asa-petersen-elected-member-executive-committee-european-huntington-disease-network-ehdn - 2026-08-19

Enormous amounts of data about Alzheimer’s Disease have been generated from clinical studies so far. Still, the molecular drivers of Alzheimer’s Disease are largely unknown. With the TAU-TIME project, Jacob Vogel aims to advance knowledge by developing an AI tool that brings together known biological mechanisms with data from patients with the disease. Recent funding from the European Research Cou

https://www.multipark.lu.se/article/time-unite-lab-and-clinic-15-million-eu-build-ai-model-alzheimers-disease - 2026-08-19

Early diagnosis is key to receiving proper care and advancing research on future therapies for neurodegenerative diseases such as Parkinson’s and dementia with Lewy bodies. New research from Skåne University Hospital and Lund University shows that combining a simple smell test with advanced spinal fluid analysis can predict these diseases with high accuracy, while sparing nearly half of patients f

https://www.multipark.lu.se/article/smell-test-cuts-need-invasive-parkinsons-screening - 2026-08-19

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement from healthcare personnel, improves the primary care physician's ability to determine who should be further examined by blood tests for Alzheimer's pathology ear

https://www.multipark.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2026-08-19

What if brain diseases could be cured by turning on the proper genes? Meet our scientist, Professor Cecilia Lundberg! She explains how gene therapy may complement cell therapies to combat Parkinson’s disease. Cecilia Lundberg is head of the CNS Gene Therapy Research Group and has spent her whole career developing cutting-edge tools that may be used in future therapies to slow down or cure neurodeg

https://www.multipark.lu.se/article/meet-our-scientists-podcast-cecilia-lundberg-about-gene-workshop - 2026-08-19

Have you ever wondered what the journey of someone living with Parkinson’s disease looks like? Meet our scientist, Professor Per Odin! He shares his experiences of the bumpy road faced by patients he has supported over the years, both in healthcare and in research studies. Parkinson’s disease is a long, challenging course; one that science works tirelessly to understand, where halting neurodegener

https://www.multipark.lu.se/article/meet-our-scientists-podcast-odin-about-parkinsons-journey - 2026-08-19

In a study led by Lund University and the Amsterdam University Medical Center, researchers used PET to analyse aggregates of tau pathology in more than 12,000 people from all over the world. The study – the largest ever of its kind – examines the connection between genetic predisposition, gender and age in relation to tau pathology in Alzheimer’s disease. The study is published in Nature Neuroscie

https://www.multipark.lu.se/article/largest-ever-taupet-study-alzheimers-deepens-understanding-disease - 2026-08-19

With an approval rate of just 17 %, this year’s Swedish Research Council grants were harder than usual to secure. Still, several of MultiPark’s group leaders were awarded major grants in Medicine and Health 2025. Receiving grants from the Swedish Research Council is seen as a mark of quality and an important step in advancing an independent research group. Recently, six MultiPark researchers were

https://www.multipark.lu.se/article/multipark-scientists-awarded-prestigious-vr-consolidator-grant - 2026-08-19

Nine researchers from MultiPark have been listed as Highly Cited Researchers by Clarivate, highlighting their significant global research impact. Clarivate acknowledges researchers whose publications rank among the top 1% most cited in their fields over the past eleven years. The selected scientists have published several highly-cited papers. Congratulations to Oskar Hansson, Shorena Janelidze, Sa

https://www.multipark.lu.se/article/multipark-researchers-recognized-clarivates-highly-cited-list - 2026-08-19

Recently, MultiPark opened its doors to the local Parkinson’s Association, who were invited behind the scenes to see how research on their condition is conducted. Here are some of the laboratories that were visited. Today’s basic research on brain disorders such as Parkinson’s may be the starting point for tomorrow’s treatments. This may explain the participants’ deep interest in MultiPark’s exper

https://www.multipark.lu.se/article/journey-discovery-research-multipark-opens-labs-parkinsons-association - 2026-08-19

The Promobilia Foundation is investing SEK 25 million in a new large-scale research project targeting Parkinson’s disease. The donation enables four research groups—one at Lund University and three at Karolinska Institutet—to join forces in developing new treatment strategies that address the root causes of the disease. Using innovative approaches, including advanced gene therapies and targeted ve

https://www.multipark.lu.se/article/promobilia-foundation-invests-sek-25-million-new-large-scale-research-project-targeting-parkinsons - 2026-08-19